Register (On-Demand) • Schedule

Psychiatric and Neurologic Medication Pipeline

Registration Options

Activity Dates: 04/10/2024 - 04/10/2027

Sign in (or create a FREE account) to register or access your existing registrations

Session Time and Location

The live session is complete.

Target Audience

If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.

Session Summary

As medication management experts, pharmacists must remain up-to-date by understanding newly marketed medications and those in the clinical development pipeline. To fulfill this role, pharmacists must master essential clinically relevant knowledge about each new medication’s efficacy for the tested indication, tolerability, and safety. This information includes the pharmacodynamic mechanism of action, pharmacokinetics, drug interactions, and pharmacoeconomics. Armed with this knowledge, pharmacists will be well-positioned to advocate for the use of the most beneficial medication by educating patients and other key stakeholders, including other prescribers. In this session, participants will learn about therapeutic advances in new and emerging psychiatric and neurologic medications and how these agents fit into current clinical practice.

Consider making this session part of your BPS Continuing Professional Development plan! Please refer to the BPS Psychiatric Pharmacy Content Outline to see how this activity may align.

Course Requirements

To receive ACPE credit for this session, you must:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date.
  • Complete the evaluation at the end of the activity.
  • If necessary, complete the post-test retest no later than the closing activity date.
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.

Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information

Stephen R. Saklad, PharmD, BCPP

View biographical information

Learning Objectives

  1. Describe the efficacy and safety data of the emerging and recently approved psychiatric and neurologic medication pipeline.
  2. Explain appropriate monitoring requirements, patient education points, and provider education for these agents.
  3. Discuss clinical use of new and emerging medications and where these agents fit into current clinical practice.

Continuing Education Credit and Disclosures

Activity Dates: 04/10/2024 - 04/10/2027
ACPE Contact Hours: 1
ACPE Number: 0284-0000-24-036-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.

ACPEThe American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.